Medications

FDA approves first liquid, nonstimulant ADHD treatment

The U.S. Food and Drug Administration has approved Tris Pharma's once-daily Onyda XR (clonidine hydrochloride) as the first liquid, nonstimulant treatment for attention-deficit/hyperactivity disorder (ADHD).

Health

WHO blames 4 major industries for 2.7 mn deaths a year in Europe

The WHO on Wednesday blamed four major industries—tobacco, ultra-processed foods (UPFs), fossil fuel and alcohol—for 2.7 million deaths a year in Europe, accusing them of obstructing public policies that could hurt their ...